VNUT-mediated ATP release suppresses T helper 1 (TH1) cell differentiation via the P2X7R-JNK-FOXO3a-Eomes signaling cascade Authors: Bolong Wu, Linlin Sheng, Ziyi Feng, Xiaohu Wang, Ligong Chen Published: 2025 ABSTRACT Extracellular ATP (eATP), a well-recognized danger signal and immune activator, is implicated in the activation, differentiation, and function of T cells, directly or indirectly. Yet, how T cells release ATP themselves and its effects remain poorly investigated. Here, we found vesicular nucleotide transporter (VNUT), critical for vesicular ATP storage/release, is highly expressed in TH1 cells and selectively restricts their differentiation and effector functions. Mechanistically, VNUT facilitates lysosomal ATP import and its extracellular release upon T cell receptor engagement. This eATP then activates the purinergic receptor P2X7R and downstream SRC kinase, triggering a signaling cascade involving heightened Ca2+ influx and hyperphosphorylation of JNK and FOXO3a, which ultimately impairs Eomes-directed IFN-γ production in TH1 cells. Genetic/pharmacological of VNUT inhibition significantly potentiates TH1 effector functions against Listeria infection and transplanted tumors. These findings identify VNUT as a critical checkpoint in limiting TH1 immunity, coupling vesicular ATP transport to transcriptional control via the P2X7R-JNK-FOXO3a-Eomes axis, offering a target for treating infection and cancer. INTRODUCTION The solute carrier family 17 member 9 (SLC17A9) is a vesicular nucleotide transporter (VNUT) that plays a pivotal role in the transport of adenosine triphosphate (ATP) into intracellular vesicles, such as lysosomes and secretory vesicles (1). As a member of the SLC17 family, VNUT is integral to the storage and regulated release of ATP, a molecule that serves not only as a universal energy currency but also as a critical signaling molecule in various physiological processes (2–4). Dysregulation of ATP transport and signaling has been implicated in a range of diseases, including cancer, metabolic disorders, and immune dysfunctions (3, 5). Despite its importance, the role of VNUT in immune cells, particularly in T cell function, remains poorly understood. CD4+ T cells, or T helper (TH) cells, are central to the adaptive immune response, orchestrating immune reactions through the secretion of cytokines and interaction with other immune cells (6). Among the CD4+ T cell subsets, TH1 cells are essential for combating intracellular pathogens by producing proinflammatory cytokines, particularly interferon-γ (IFN-γ) (7). IFN-γ enhances macrophage activation, promotes antigen presentation, and supports the development of cytotoxic T cells (8). However, dysregulated TH1 responses are associated with various autoimmune diseases, cancer, and infectious diseases, highlighting the need for precise regulatory mechanisms to control TH1 differentiation and function (9). FOXO transcription factors, including FOXO1 and FOXO3, are key regulators of T cell differentiation and function. FOXO1 is known to inhibit TH1 differentiation by directly binding to the promoter region of the Ifng gene and suppressing its expression (10). Additionally, FOXO1 promotes the generation of regulatory T (Treg) cells and inhibits the differentiation of T follicular helper and TH17 cells (10). FOXO3a, on the other hand, has been shown to promote the differentiation of pathogenic TH cells by up-regulating the expression of eomesodermin (Eomes), a transcription factor critical for TH1 cell function (11). In spite of these insights, the molecular mechanisms underlying FOXO3a regulation in T cells, particularly in response to T cell receptor (TCR) signaling, remain incompletely understood (12). Eomes is a T-box transcription factor critical for immune cell development and function. Initially identified for its role in embryonic development (13), Eomes is highly expressed in immune cells, including CD8+ cytotoxic T cells (14), natural killer (NK) cells (15), and a subset of CD4+ T cells (16). It regulates genes involved in cytotoxicity (e.g., granzyme B and perforin) (17), cytokine production (e.g., IFN-γ) (11), and cell survival (18). While its function in CD8+ T cells and NK cells is well characterized, emerging evidence highlights its importance in modulating CD4+ T cell plasticity (19), differentiation (11), and function (14). Eomes collaborates with T-bet (another T-box factor) to drive TH1 polarization and IFN-γ production (19). Previous studies have identified extracellular ATP (eATP) as a core early danger signal and potent activator of the innate immune system, which is involved in a variety of immune responses and pathogenic processes, including infection, inflammation, and cancer (20). Beyond its role in innate immunity, accumulating evidence also highlights eATP as an activator of T cells (21). For instances, TCR stimulation can trigger the rapid release of eATP, and this eATP release directly contributes to T cell activation by facilitating calcium influx and promoting the production of interleukin-2 (IL-2). Additionally, microbial-derived eATP promotes the induction of intestinal TH17 cells, through driving CD70hi CD11clo lamina propria cells to secrete TH17-prone cytokines (22). Moreover, eATP has been reported to dampen the suppressive activity of Treg cells and promote their conversion to TH17 cells (23), promote the accumulation of CD4+ T cells during severe lung infections (24), maintain the metabolic fitness of long-lived memory CD8+ T cells (25), and regulate the development of CD8+ central memory T cells and resident memory T cells (26) mainly through acting on the purinergic receptor P2X7R. Despite these findings, the upstream mechanisms that control eATP release, its downstream signaling cascades and the functional consequences in T cells, remain largely unclear. In this study, we investigated the role of VNUT in T cells by generating CD4+ T cell–specific conditional knockout (cKO) mice and discovered that its knockout (KO) substantially enhances IFN-γ production and TH1 cell function both in vitro and in vivo. Combining pharmacological and genetic tools, we identified a previously identified signaling axis involving P2X7R-JNK-FOXO3a-Eomes that regulates TH1 differentiation. Our findings provide insights into the molecular mechanisms by which VNUT modulates TH1 cell function and highlight its potential as a therapeutic target for immune-related diseases. RESULTS Vnut deficiency augments TH1 differentiation Analysis of transcriptomic profiling data revealed elevated Vnut expression levels in mature naïve CD4+ T lymphocytes (Fig. 1A), suggesting a putative role for VNUT in modulating effector functions of adaptive immune cells. To investigate the cell-intrinsic function of VNUT in CD4+ T cells, we generated Vnut flox/flox [wild-type (WT)] mice and crossed them with Cd4-Cre mice to obtain CD4+ T cell–specific cKO mice and validated its KO efficiency (Fig. 1B). Vnut deficiency enhances TH1 differentiation both in vitro and in vivo. (A) Vnut expression value across different stages of CD4+ T cells. (B) Real-time qPCR analysis of relative Vnut mRNA level in CD4+ T cells isolated from WT and Vnut-cKO mice. Data (n = 4) are from four independent experiments. (C and D) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1, TH2, TH17, and iTreg lineages in the presence of a protein transport inhibitor in the last 5 hours. FSC, forward scatter. Data (n = 3) are from three independent experiments. (E) Real-time qPCR analysis of relative Vnut mRNA level in different CD4+ T cell subsets. Data (n = 3) are from three independent experiments. (F) Real-time qPCR analysis of Ifng, Tbx21, Stat4, and Runx3 in CD4+ T cells isolated from WT and Vnut-cKO mice followed by stimulation for 3 days with plate-bound anti-CD3 and anti-CD28 in TH1-polarizing conditions. Data (n = 4) are from four independent experiments. (G and H) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with the treatment of different concentration of VNUT inhibitor. Data (n = 4) are from two independent experiments. (I) Intracellular staining for IFN-γ in WT and Vnut-cKO CD4+ T cells with or without keyhole limpet hemocyanin (KLH) stimulation (0 or 100 μg/ml) from spleens of mice 7 days after KLH/Freund’s complete adjuvant (FCA) immunization. Data (n = 4) are from two independent experiments. (J) Frequency of IFN-γ–expressing cells in dLN CD4+ T cells. Data (n = 4) are from two independent experiments. Data are presented as means ± SEM. Not significant (n.s.), P > 0.05; **P < 0.01; ***P < 0.001 (unpaired two-tailed Student’s t test). We first evaluated whether Vnut deficiency compromises CD4+ T cell maturation or homeostasis. Thymocyte analysis by flow cytometry showed comparable T cell maturation between WT and cKO mice (fig. S1, A and B), including the development of CD4+, CD8+, and the double-positive thymocytes. Mature T cells migrate to peripheral lymphoid organs such as the spleen and lymph nodes. Vnut deficiency had no notable impact on spleen morphology or weight (fig. S1, C and D). Immune cell composition in spleen (fig. S1, E to G) and lymph nodes (fig. S1, H to J) remained unaltered. Moreover, no notable alterations were observed in CD44/CD62L or FOXP3 expression profiles (fig. S2, A and B), proliferation kinetics (fig. S2C), or viability parameters (fig. S2, D to F), collectively indicating that VNUT deletion does not compromise T cell homeostasis. In vitro polarization assays revealed a selective enhancement of TH1 differentiation in Vnut-deficient CD4+ T cells, whereas TH2, TH17, Treg. and CD8+ T cell differentiation remained comparable (Fig. 1, C and D; and fig. S3, A and B), aligned with the highest expression of Vnut in TH1 subsets (Fig. 1E). Upon in vitro activation with polarizing cytokines, cKO T cells exhibited a marked increase in IFN-γ–producing cells compared to that in WT controls. This phenotype was confirmed at the transcriptional level by quantitative polymerase chain reaction (qPCR) analysis, demonstrating a notable up-regulation of Ifng mRNA in cKO TH1 cells (Fig. 1F and fig. S3C). Treatment with the VNUT inhibitor clodronate disodium caused a dose-dependent increase in the proportion of IFN-γ–positive cells in TH1 cultures (Fig. 1, G and H), without affecting the overall cell viability (fig. S3D). The differentiation of TH2, TH17, and Treg cells was not altered under VNUTi treatment, which is consistent with the results obtained from genetic ablation of Vnut (fig. S3, E and F). To assess the in vivo relevance of these findings, we used a mouse immunization model using keyhole limpet hemocyanin (KLH) and Freund’s complete adjuvant (FCA). Consistent with in vitro results, a marked increase in IFN-γ–positive cells was observed in cKO mice (Fig. 1, I and J), indicating that VNUT also modulates IFN-γ production in vivo. Meanwhile, Vnut deficiency had no impact on TH17 or Treg in KLH immune model (fig. S4, A and B), matching the results of in vitro differentiation. Collectively, these data reveal a specific function of VNUT in regulating the differentiation of TH1 but not TH2, TH17, or Treg cells, both in vitro and in vivo. VNUT regulates TH1 differentiation independently of IL-12 and IFN-γ signaling pathways To dissect the molecular basis of VNUT’s regulatory function in TH1 cells, we systematically profiled the canonical IL-12 and IFN-γ signaling pathways. Given the TH1-restricted phenotype in Vnut-deficient mice, we hypothesized that VNUT may modulate TH1 differentiation through these pathways. To test this hypothesis, we titrated IL-12 stimulation (1.5 to 150 ng/ml) during in vitro differentiation of WT and cKO TH1 cells. Quantitative analysis revealed that Vnut deficiency–induced elevation in IFN-γ production remained consistent across all IL-12 concentrations tested (fig. S5A). Western blot analysis of signaling nodes [Janus kinase 2 (JAK2) and signal transducer and activator of transcription 4 (STAT4)] demonstrated no measurable differences in total protein expression or phosphorylation states between WT and cKO cells (fig. S5B). These data indicate that VNUT does not operate through the IL-12 signaling axis to regulate TH1 differentiation. We next evaluated the potential involvement of the IFN-γ autocrine loop by treating differentiating TH1 cells with anti–IFN-γ neutralizing antibodies. Although antibody treatment suppressed IFN-γ production in both WT and cKO cells, the genotype-dependent disparity persisted (fig. S5, C and D). Correspondingly, no substantial changes were detected in JAK1/STAT1 phosphorylation patterns or total protein levels (fig. S5E), excluding a direct role for IFN-γ signaling in mediating VNUT’s regulatory effects. Collectively, these experiments establish that VNUT modulates TH1 IFN-γ production through a mechanism that is functionally disassociated from both the IL-12/JAK2/STAT4 and IFN-γ/JAK1/STAT1 signaling pathways. This observation suggests the existence of previously uncharacterized molecular targets through which VNUT exerts selective control over TH1 cytokine expression. VNUT modulates TH1 differentiation through TCR-dependent JNK signaling pathway Building on our mechanistic hypothesis, we posited that VNUT governs TH1 cell differentiation via TCR signaling cascades. To test this, WT and cKO cells were activated with titrated anti-CD3 antibody during TH1 differentiation. Notably, the IFN-γ production disparity between genotypes amplified dose dependently (Fig. 2, A and B), implicating TCR signal strength dependence in VNUT-mediated regulation. To dissect downstream effectors, we pharmacologically blocked key TCR signaling nodes. Selective JNK inhibition (SP600125) abrogated the genotype-specific IFN-γ difference (Fig. 2, C and D). In contrast, other inhibitors altered IFN-γ production in both groups but preserved the difference between WT and cKO cells (Fig. 2, C and D). This functional specificity pinpoints JNK as the primary conduit of VNUT’s regulatory action. VNUT negatively regulates TH1 differentiation via JNK phosphorylation. (A and B) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with different concentration of plate-bound CD3. Data (n = 3) are from three independent experiments. (C and D) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with different inhibitor treatment. Data (n = 4) are from four independent experiments. DMSO, dimethyl sulfoxide. (E) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with different concentration of JNK inhibitor treatment. Data (n = 4) are from four independent experiments. (F) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with different concentration of JNK agonist treatment. Data (n = 4) are from four independent experiments. (G) Western blot analysis of JNK and phospho-JNK protein level in cultured CD4+ T cells from WT and Vnut-cKO mice in TH1-polarizing conditions. Data (n = 4) are from four independent experiments. Data are presented as means ± SEM. n.s., P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired two-tailed Student’s t test). Orthogonal validation using a distinct JNK inhibitor (JNK-IN-8) recapitulated phenotype abolition (fig. S6, A and B). Dose-response analysis revealed that JNK inhibition caused concentration-dependent increases in IFN-γ production in WT cells, ultimately eliminating genotypic differences (Fig. 2E and fig. S6C). Complementary gain-of-function experiments using the JNK activator anisomycin dose-dependently suppressed IFN-γ production in WT cells (Fig. 2F and fig. S6D), further cementing JNK as the central regulatory node. Additional experiments demonstrated a marked reduction in JNK phosphorylation in both cKO (Fig. 2G and fig. S6E) and VNUT inhibitor–treated cells (fig. S6F). These data collectively establish that VNUT inhibits TH1 differentiation likely through suppressing JNK activity. VNUT regulates TH1 differentiation through the JNK-FOXO3a-Eomes signaling axis To mechanistically dissect the function of VNUT in TH1 cells, we conducted RNA sequencing (RNA-seq) profiling of WT and cKO TH1 cells. Pathway enrichment and gene set enrichment analysis revealed potentiated TH1 differentiation signatures in cKO cells (fig. S7, A and B). Analysis of differentially expressed transcription factors identified a marked up-regulation of Eomes in cKO cells (Fig. 3A), an important regulator of TH1 differentiation (11). Orthogonal validation by qPCR and immunoblotting confirmed Eomes mRNA and protein elevation in both genetic (cKO) and pharmacological (VNUT inhibitor–treated) models (Fig. 3, B and C; and fig. S7, C and D). Vnut deficiency enhances FOXO3a function and leads to higher Eomes level. (A) Differentially expressed genes from RNA-seq result. Data (n = 4) are from four independent experiments. FC, fold change. (B) qPCR and (C) Western blot of Eomes in WT and Vnut-cKO TH1 cells. Data (n = 3 to 4) are from two or three independent experiments. (D) qPCR analysis of Eomes at different time point. Data (n = 4) are from two independent experiments. h, hours. (E and F) Flow cytometric analysis of the result of Eomes overexpression in TH1 cells. Data (n = 4) are from two independent experiments. (G) Western blot analysis of FOXO3a and phospho-FOXO3a in WT and Vnut-cKO TH1 cells. Data (n = 4) are from four independent experiments. (H) Western blot analysis of nucleic FOXO3a and cytosolic phospho-FOXO3a in WT and Vnut-cKO TH1 cells. Data (n = 4) are from two independent experiments. (I) ChIP-qPCR analysis to validate the high binding efficiency of FOXO3a at Eomes FOXO-binding-site (FBS) in Vnut-cKO TH1 cells. Data (n = 3) are from three independent experiments. (J and K) Flow cytometric analysis of the result of FOXO3a overexpression in TH1 cells. Data (n = 6) are from three independent experiments. (L) Western blot analysis of FOXO3a and Eomes in TH1 cells with/without FOXO3a overexpression. Data (n = 4) are from two independent experiments. (M) Western blot analysis of FOXO3a, phospho-FOXO3a, and Eomes in TH1 cells with/without JNK inhibitor treatment. Data (n = 4) are from four independent experiments. (N) ChIP-qPCR analysis to validate the high binding efficiency of FOXO3a at Eomes FBS in JNK inhibitor-treated TH1 cells. Data (n = 3) are from three independent experiments. Data are presented as means ± SEM. n.s., P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired two-tailed Student’s t test). Given that Eomes expression occurs during early differentiation, we assessed Eomes expression at various time points. Eomes levels were consistently higher in cKO cells during all differentiation periods (Fig. 3D). Furthermore, overexpression of Eomes in TH1 cells not only enhanced differentiation but also abolished the difference between WT and cKO cells (Fig. 3, E and F), underscoring the importance of Eomes. Previous studies suggest that Eomes expression in T cells is regulated by the TCR signaling pathway, consistent with our findings that VNUT modulates TH1 function via TCR signaling. Additionally, FOXO3a has been reported to regulate Eomes expression (11). In our system, while total FOXO3a protein levels remained unchanged, FOXO3a phosphorylation at the S253 and S318 residues, which promotes its nuclear exclusion and functional inactivation, was substantially reduced in cKO cells (Fig. 3G and fig. S7E), suggesting increased FOXO3a transcriptional activity in cKO cells. Nuclear isolation experiments confirmed higher FOXO3a levels in cKO cell nuclei (Fig. 3H and fig. S7F). Immuno-fluorescent also revealed a nucleic retention of FOXO3a in cKO cells (fig. S7G). Chromatin immunoprecipitation (ChIP)–qPCR further revealed enhanced FOXO3a binding to the Eomes promoter in cKO cells (Fig. 3I). To further validate FOXO3a’s role, we inhibited its nuclear translocation, reducing IFN-γ–positive cells in both WT and cKO samples and eliminating their differences (fig. S7H). Conversely, point-mutated FOXO3a (S318→A) overexpression in WT TH1 cells substantially increased IFN-γ–positive cells (Fig. 3, J and K). FOXO3a overexpression also elevated Eomes protein levels (Fig. 3L and S7I), confirming its critical role in VNUT-mediated TH1 regulation. To investigate the functional link between JNK and FOXO3a, we detected FOXO3a phosphorylation level in TH1 cells cultured with or without the JNK inhibitor SP600125. Treatment with the JNK inhibitor markedly reduced FOXO3a phosphorylation (S318 and S253) and increased Eomes protein levels (Fig. 3M and fig. S7J). ChIP-qPCR also showed enhanced FOXO3a binding to the Eomes promoter following JNK inhibition (Fig. 3N). These results demonstrate that VNUT regulates TH1 differentiation through the JNK-FOXO3a-Eomes signaling axis. VNUT-mediated lysosomal ATP release controls TH1 differentiation VNUT has been implicated in the storage and release of ATP within vesicular structures and is localized to lysosomes, as confirmed by colocalization experiments (fig. S8A). To assess the role of VNUT in lysosomal ATP storage, lysosomes were isolated from WT and cKO TH1 cells. Lysosomal ATP levels were notably reduced in cKO cells compared to WT cells (Fig. 4A), indicating VNUT’s involvement in lysosomal ATP storage. 2′/3′-O-(N-methylanthraniloyl)–ATP (MANT-ATP), a fluorescently conjugated ATP analog that has been widely used to track ATP uptake and turnover, including VNUT-mediated uptake and accumulation in the lysosomes (27, 28). MANT-ATP uptake assays further revealed reduced fluorescent intensity in cKO cells (Fig. 4B), supporting the role of VNUT in ATP transport in TH1 cells. Meanwhile, Vnut KO did not alter total cellular level of ATP in both naïve CD4+ T and TH1 cells, and Vnut KO exerted little impacts on overall metabolic state of TH1 cell (fig. S8, B to E). VNUT mediates ATP release regulates TH1 differentiation. (A) Lysosome ATP measurement in WT and Vnut-cKO TH1 cells. Data (n = 4) are from four independent experiments. (B) Flow cytometric analysis of the MANT-ATP loading in WT and Vnut-cKO TH1 cells. MFI, mean fluorescence intensity. Data (n = 3) are from three independent experiments. (C) eATP measurement of WT and Vnut-cKO naïve CD4+ T cells before and after CD3 and CD38 stimulation (n = 4). Data (n = 4) are from four independent experiments. (D and E) Flow cytometric analysis of TH1 cell differentiation with/without bafilomycin A1 treatment. Data (n = 4) are from four independent experiments. (F) eATP measurement of naïve CD4+ T cells before and after CD3 and CD38 stimulation with/without bafilomycin A1 treatment. Data (n = 3) are from three independent experiments. (G and H) Flow cytometric analysis of TH1 differentiation with/without LLOMe treatment. Data (n = 4) are from four independent experiments. (I) eATP measurement of naïve CD4+ T cells before and after CD3 and CD38 stimulation with/without LLOMe treatment. Data (n = 3) are from three independent experiments. (J) Western blot analysis of FOXO3a, phospho-FOXO3a, JNK, and phospho-JNK in cultured TH1 cells with/without LLOMe treatment. Data (n = 4) are from two independent experiments. (K) Flow cytometric analysis of TH1 differentiation with/without BzATP treatment. Data (n = 4) are from four independent experiments. (L) Western blot analysis of FOXO3a, phospho-FOXO3a, JNK, and phospho-JNK in cultured TH1 cells with/without BzATP treatment. Data (n = 4) are from two independent experiments. Data are presented as means ± SEM. n.s., P > 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (unpaired two-tailed Student’s t test). Previous studies have demonstrated that T cells release ATP upon stimulation, a process regulated by VNUT (29). To validate this, naïve CD4+ T cells from WT and cKO mice were stimulated with CD3 and CD28 in vitro, and eATP levels were measured. Stimulated cKO cells exhibited markedly lower eATP levels compared to WT cells (Fig. 4C). Additionally, treatment with a VNUT inhibitor resulted in a similar reduction in eATP levels (fig. S8F), further confirming the regulatory role of VNUT in ATP release. Moreover, lysosomes are known to participate in ATP release upon cell stimulation in several nonneuronal cell types (27, 30). Measurement of acid phosphatase levels in the extracellular compartment poststimulation revealed a substantial increase (fig. S8G), suggesting lysosomal involvement in VNUT-mediated ATP release in T cells. To investigate whether eATP regulates TH1 cell differentiation, cells were treated with Baf-A1, an inhibitor of ATP release upon cell stimulation (29). In differentiation experiments, Baf-A1 treatment increased the proportion of IFN-γ–positive cells (Fig. 4, D and E). Consistent with its inhibitory effect, eATP levels were markedly reduced following Baf-A1 treatment (Fig. 4F), indicating that ATP release following T cell stimulation negatively regulates IFN-γ production. To determine whether lysosomal ATP release is the key regulatory factor, lysosomes were disrupted using Leu-Leu methyl ester hydrobromide (LLOMe). In vitro differentiation experiments demonstrated that LLOMe-induced lysosomal disruption substantially increased the proportion of IFN-γ–positive cells (Fig. 4, G and H). eATP levels were markedly reduced in LLOMe-treated, stimulated T cells (Fig. 4I), confirming that lysosomal disruption impairs ATP release. To exclude compound-specific effects, cells were treated with GPN, which yielded results similar to those observed with LLOMe (fig. S8, H and I). Additionally, LLOMe treatment reduced levels of phosphorylated JNK (phospho-JNK) and phosphorylated FOXO3a (phospho-FOXO3a; Fig. 4J and fig. S8J). Furthermore, treatment with the ATP analog BzATP during in vitro differentiation experiments eliminated the differences between WT and cKO cells (Fig. 4K) and increased levels of phospho-FOXO3a and phospho-JNK (Fig. 4L and fig. S8K). These findings collectively suggest that VNUT-mediated ATP release plays a vital role in regulating TH1 differentiation. Mechanistic role of P2X7 receptor in VNUT-dependent regulation of TH1 differentiation To elucidate the mechanism by which VNUT-mediated ATP release regulates TH1 cell function, we explored the literature and identified that T cells express a series of purinergic receptors on their surface, which interact with extracellular nucleotides to modulate T cell function. RNA-seq analysis revealed that P2X4R and P2X7R are the primary purinergic receptors expressed on TH1 cells, with P2X7R exhibiting the highest expression levels (fig. S9A). To determine whether P2X7R plays a critical role in TH1 cell regulation, we treated WT and cKO cells with a P2X7R antagonist (A-438079) during in vitro differentiation. This treatment markedly increased the proportion of IFN-γ–positive cells and eliminated the differences between WT and cKO cells (Fig. 5, A and B). These findings were further validated using an additional P2X7R antagonist (A-804598), which yielded similar results (fig. S9, B and C). Furthermore, P2X7R inhibition led to a marked reduction in the phosphorylation of JNK and FOXO3a (Fig. 5C and fig. S9D), consistent with the effects observed in Vnut KO cells. Consistent with the results of P2X7R inhibitor treatment. Targeting P2x7r by single guide RNA resulted in a robustly enhanced TH1 differentiation (Fig. 5 and fig. S9E), further suggesting P2X7R as a critical mediator in this regulatory pathway. VNUT regulates TH1 differentiation via P2X7R. (A and B) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with/without ATP receptor P2X7R inhibitor treatment. Data (n = 4) are from four independent experiments. (C) Western blot analysis of FOXO3a, phospho-FOXO3a, JNK, phospho-JNK, and Eomes protein level in cultured TH1 cells with/without P2X7R inhibitor treatment. Data (n = 4) are from two independent experiments. CTR, control. (D and E) Flow cytometric analysis of the result of P2X7R KO in TH1 cells. Data (n = 3) are from three independent experiments. (F) Western blot analysis of SRC and phospho-SRC protein level in cultured WT and Vnut-KO TH1 cells. Data (n = 4) are from two independent experiments. (G and H) Flow cytometric analysis of naïve CD4+ T cells after 3 days of polarization toward the TH1 with/without SRC inhibitor treatment. Data (n = 4) are from four independent experiments. (I) Western blot analysis of FOXO3a, phospho-FOXO3a, JNK, phospho-JNK, and Eomes protein level in cultured TH1 cells with/without SRC inhibitor treatment. Data (n = 4) are from two independent experiments. (J) Western blot analysis of SRC and phospho-SRC protein level under DMSO or P2X7R inhibitor treatment. Data (n = 4) are from two independent experiments. Data are presented as means ± SEM. n.s., P > 0.05; ***P < 0.001 (unpaired two-tailed Student’s t test). Recent studies have shown that the intracellular C-terminal domain of P2X7R directly interacts with Src family kinases, such as c-Src, to modulate downstream signaling pathways (31). Consistently, Vnut cKO TH1 cells exhibited markedly reduced Src phosphorylation levels, compared to WT control cells (Fig. 5F and fig. S9F). To investigate whether Src kinase activity plays a role in this regulatory system, we treated WT and cKO cells with Src inhibitors (SRCi) during differentiation. Inhibition of Src kinase activity enhanced TH1 differentiation in vitro, and the proportion of IFN-γ–positive cells in WT and cKO cells became nearly identical following inhibitor treatment (Fig. 5, G and H), suggesting that Src kinase is essential for VNUT-mediated regulation of TH1 differentiation. To further validate these findings, proteins were isolated from WT cells under normal conditions and after Src inhibitor treatment, followed by Western blot analysis of key proteins involved in VNUT-regulated TH1 differentiation. Src inhibitor treatment notably reduced the phosphorylation levels of JNK and FOXO3a compared to normal conditions (Fig. 5I and fig. S9G), recapitulating the effects observed in Vnut KO cells. Moreover, P2X7R inhibition substantially reduced Src phosphorylation levels (Fig. 5J and fig. S9H), establishing a direct link between P2X7R activation and Src kinase signaling. These data collectively establish that VNUT-dependent ATP release governs TH1 cell differentiation through a P2X7R-Src kinase axis, which subsequently modulates JNK and FOXO3a phosphorylation to fine-tune TH1 effector function. Critical role of ATP-induced Ca2+ influx in VNUT-mediated TH1 differentiation Previous studies suggest that eATP can signal through P2X7R and induce Ca2+ influx (32). To determine whether VNUT functions through modulating Ca2+ influx in stimulated T cells, we stained cells with the Ca2+ fluorescent probe Fluo-4 and stimulated them with a mixture of CD3 and CD28. Upon stimulation, the fluorescence intensity of WT cells increased notably, indicating robust Ca2+ influx. In contrast, the fluorescence intensity of cKO cells was markedly lower than that of WT cells (fig. S10A), demonstrating that Vnut KO markedly inhibits Ca2+ influx in naïve CD4+ T cells upon stimulation. This difference in Ca2+ concentration may contribute to the divergent differentiation phenotypes observed between WT and cKO cells. To assess whether Ca2+ influx and intracellular Ca2+ concentration changes influence these phenotypes, we treated WT and cKO cells with the pan-Ca2+ influx inhibitor nilvadipine during in vitro differentiation assays. Nilvadipine treatment impaired Ca2+ influx (fig. S10A) while substantially increasing the proportion of IFN-γ–positive cells, indicating that inhibiting Ca2+ influx promotes TH1 differentiation (fig. S10, B and C), consistent with our earlier findings. Furthermore, the differences in IFN-γ–positive cell proportions between WT and cKO cells were abolished after nilvadipine treatment (fig. S10, B and C), demonstrating that Ca2+ influx is a critical pathway through which VNUT regulates TH1 differentiation. Western blot analysis of proteins isolated from WT cells under normal conditions and after nilvadipine treatment revealed substantial reductions in phospho-JNK and phospho-FOXO3a in treated cells (fig. S10D), consistent with the effects of Vnut KO. These results underscore the pivotal role of Ca2+ influx in VNUT-mediated TH1 differentiation. To further investigate the influence of Ca2+ on these phenotypes, we adjusted Ca2+ concentrations in the culture medium during in vitro differentiation assays. Ca2+ influx represents one of the most pronounced TCR downstream signaling events, which is tightly controlled in T cell activation and differentiation. As expected, deprivation of Ca2+ or its excessive presence in the culture medium markedly inhibited the differentiation of TH1 cells (fig. S10, E and F) and also abrogated the difference of IFN-γ production between WT and cKO cells (fig. S10, E and F). These findings further support a function link between VNUT and Ca2+ influx in modulating TH1 differentiation and IFN-γ production. In line with altered Ca2+ influx in Vnut cKO cells, phosphorylation of the Ca2+-dependent kinase calcium- and calmodulin-dependent protein kinase II (CaMKII) was markedly reduced in cKO cells compared to that in WT cells, despite that the total level of CaMKII was not affected (fig. S10G). To understand the functional consequence of reduced CaMKII phosphorylation, we used a CaMKII inhibitor (KN93) during in vitro differentiation assays. Treatment with the CaMKII inhibitor not only enhanced TH1 cell differentiation but also abolished the differences between WT and cKO cells, as judged by IFN-γ production (fig. S10, H and I), suggesting an essential role of CaMKII in VNUT-mediated TH1 differentiation. Combined SRCi and KN93 treatment exerted a more pronounced enhancement on TH1 differentiation compared to either SRCi or KN93 alone (fig. S10, J and K). These findings indicate that SRC and CaMKII, which function as downstream effectors of P2X7R, act synergistically to regulate TH1 differentiation. Collectively, these data suggest that VNUT governs TH1 differentiation through synergistic actions between Ca2+ influx–activated CaMKII and SRC. Vnut KO enhanced pathogen clearance and antitumor immune responses To investigate whether VNUT regulates TH1 cell function under physiologically relevant settings, we established several TH1 associated disease models. TH1 cells produce IFN-γ, which plays a critical role in multiple immune processes (33), including inducing the expression of antimicrobial peptides in macrophages, enhancing macrophage phagocytosis and Listeria-killing capabilities, stimulating nitric oxide production in macrophages to eliminate bacteria, and promoting the recruitment of additional immune cells to infection sites, thereby aiding bacterial clearance. We constructed a Listeria clearance model by intravenously injecting mice with 105 colony-forming units (CFU) of Listeria and conducted experiments 7 days postinfection (fig. S11A). cKO mice exhibited notably fewer Listeria colonies in the spleen and liver compared to WT mice (Fig. 6A and fig. S11B), indicating that VNUT KO accelerates Listeria clearance in these organs. Analysis of T cell function in the spleen (Fig. 6, B and C) and liver (Fig. 6, D and E) revealed that CD4+ T cells from cKO mice produced substantially higher levels of IFN-γ compared to those from WT mice. Serum IFN-γ levels were also elevated in cKO mice (fig. S11C). In contrast, there was no difference in IFN-γ expression in WT and Vnut-KO CD8+ T cells (fig. S11D). Of note, depletion of CD4+ T cells using anti-CD4 antibodies not only impaired the clearance of Listeria but also eliminated the difference of bacterial burden between WT and cKO mice (fig. S11E) These findings thus demonstrate that VNUT functions through CD4+ rather than CD8+ T cells in modulating immune response against Listeria. Vnut deficiency accelerates Listeria elimination and restricts transplanted tumor growth. (A) L. monocytogenes titers in the spleens and livers of WT and Vnut-cKO mice infected with Lm-OVA for 7 days, shown as CFU. Data (n = 10) are from two independent experiments. (B to E) Flow cytometric analysis of IFN-γ–producing CD4+ T cells in the spleen [(B) and (C)] or liver [(D) and (E)] after 5 hours of restimulation with LLO190-201 peptide in the presence of a protein transport inhibitor. Data (n = 4) are from two independent experiments. (F) The size of transplanted MC38 tumor of WT and Vnut-cKO mice. Data (n = 8 to 12) are from two independent experiments. (G) The weight of transplanted MC38 tumor of WT and Vnut-cKO mice 24 days after transplantation. Data (n = 8 to 12) are from two independent experiments. (H and I) Flow cytometric analysis of tumor-infiltrating CD4+ T cells in the spleen 24 days after transplantation. Data (n = 9) are from two independent experiments. (J and K) Flow cytometric analysis of IFN-γ–producing CD4+ tumor-infiltrating T cells. Data (n = 9) are from two independent experiments. (L) The size of transplanted MC38 tumor of PBS and VNUT inhibitor (administered every 3 days, starting 9 days after tumor transplantation) treated mice. Data (n = 5) are from one independent experiment. (M) The weight of transplanted MC38 tumor of PBS and VNUT inhibitor treated mice 24 days after transplantation. Data (n = 5) are from one independent experiment. (N) The diagram of transplanted MC38 tumor of PBS and VNUT inhibitor treated mice 24 days after transplantation. Data (n = 5) are from one independent experiment. Data are presented as means ± SEM. n.s., P > 0.05; *P < 0.05; ***P < 0.001; ****P < 0.0001 (unpaired two-tailed Student’s t test). TH1 cells and IFN-γ play a dual role in tumor immunity (34), exhibiting both antitumor and protumor effects. On one hand, IFN-γ can activate macrophages and enhance the function of CD8+ T cells and NK cells, contributing to tumor cell clearance. On the other hand, IFN-γ can promote the expression of immune checkpoint molecules like PD-1, potentially leading to tumor immune evasion. To determine whether VNUT regulates TH1 cell function in tumor immunity, we established an MC38 tumor transplantation model by subcutaneously injecting 2 × 106 MC38 tumor cells into the inguinal region of WT and cKO mice (fig. S11F). By day 11 posttransplantation, tumors in cKO mice were markedly smaller than those in WT mice (Fig. 6F). Tumor weight measurements confirmed that tumors in cKO mice were markedly lighter than those in WT mice (Fig. 6G), demonstrating that VNUT deletion in CD4+ T cells inhibits MC38 tumor growth. Flow cytometry analysis revealed a substantial increase of tumor-infiltrating CD4+ T cells in cKO mice compared to that in WT mice (Fig. 6, H and I). Further analysis showed that the proportion of IFN-γ–expressing CD4+ T cells was markedly higher in tumors from cKO mice (Fig. 6, J and K), suggesting that Vnut deletion enhances antitumor response by elevated TH1 responses. Of our interest, treatment with the VNUT inhibitor clodronate disodium markedly suppressed transplanted tumor growth (Fig. 6, L to N), suggesting further application of targeting VNUT in antitumor therapy. To investigate the potential applications of VNUT inhibitors, we further isolated naïve CD4+ T cells from human peripheral blood mononuclear cells (PBMCs) and performed in vitro differentiation assays. Treatment with the VNUT inhibitor substantially enhanced human TH1 cell differentiation (fig. S12, A and B). Similar to murine TH1 culture, VNUTi treatment exerted no notable impact on the expression of T-bet while causing reduced phosphorylation of JNK and FOXO3a and up-regulated the protein level of Eomes in human TH1 cells (fig. S12, C to F). Collectively, these results suggest that VNUT regulates TH1 cell–mediated IFN-γ production, which critically affects both antibacterial defenses and antitumor responses. These findings further implicate VNUT as a potential therapeutic target for the treatment of diseases in which TH1 cells are involved, including both cancer and infectious diseases. DISCUSSION The present study elucidates a previously uncharacterized role of VNUT in governing TH1 cell differentiation through a lysosomal ATP-dependent signaling axis, thereby expanding its functional relevance beyond vesicular ATP transport to include direct modulation of adaptive immune responses. Our findings suggest that eATP released by VNUT, instead of acting as an immune activator, suppresses TH1 effector functions by modulating the activation of P2X7R and the downstream JNK-FOXO3a-Eomes signaling cascade (fig. S13). Central to this regulatory network is the lysosomal localization of VNUT in T cells, corroborating its canonical role as a vesicular ATP transporter while revealing its functional indispensability in maintaining lysosomal ATP pools. Genetic ablation of VNUT disrupted lysosomal ATP storage and extracellular release following TCR stimulation, concomitant with impaired MANT-ATP uptake, a finding that aligns with prior reports of VNUT-dependent ATP transport in nonneuronal systems (3, 29, 35). Notably, VNUT deficiency also altered lysosomal abundance and acidification, suggesting potential pleiotropic effects on lysosomal homeostasis. While the direct functional consequences of these structural perturbations remain to be explored, our data emphasize that VNUT’s primary contribution to TH1 regulation lies in its ATP transport activity, as pharmacological inhibition of ATP release (via bafilomycin A1) or eATP signaling (via P2X7R antagonism) phenocopied the enhanced TH1 differentiation observed in VNUT-deficient cells. The downstream signaling cascade delineated here—P2X7R activation, SRC-mediated JNK phosphorylation, and subsequent FOXO3a inactivation—provides mechanistic clarity to longstanding observations linking TCR signaling to FOXO3a transcriptional activity (11). By demonstrating that TCR stimulation induces lysosomal ATP release to activate surface P2X7R, we propose a feedforward loop wherein TCR engagement initiates not only canonical signaling pathways but also vesicular nucleotide secretion. P2X7R activation regulates the phosphorylation of SRC, which matches a previous report that P2X7R can influence SRC activation via its C-terminal domain (31). As one of the key TCR downstream signaling events, proper amount of Ca2+ influx is required for effective T cell activation and differentiation. In line with this, in the Ca2+ titration experiment, we found that Ca2+ promoted TH1 differentiation only under a very narrow window of concentration, while its deprivation or excessive presence in the culture medium not only impaired TH1 cell differentiation but also abrogated the differences between WT and cKO cells (fig. S10, E and F). This finding further demonstrated that regulation of TH1 differentiation via VNUT is mediated by Ca2+ signaling. While JNK-mediated phosphorylation of FOXO3a has been shown to promote its nuclear translocation in certain cell types (36), our study reveals a distinct regulatory mechanism in TH1 cells. Specifically, JNK phosphorylates FOXO3a at serine residues 318 and 253, triggering nuclear exclusion of the transcription factor and subsequent suppression of Eomes expression. This spatial regulation of FOXO3a establishes a previously unidentified molecular link between purinergic signaling and the transcriptional program governing TH1 cell differentiation, suggesting that phosphorylation-dependent nucleocytoplasmic shuttling serves as a critical checkpoint in T cell lineage specification. This aligns with prior work implicating FOXO3a as a rheostat for Eomes expression (11), yet our findings redefine its regulation as a process dynamically modulated by eATP gradients, a concept with broad implications for understanding microenvironmental influences on T cell differentiation. While this study focuses on VNUT’s role in TH1 differentiation, the broader implications of lysosomal ATP transport in T cell biology warrant consideration. The observed dysregulation of lysosomal parameters in VNUT-deficient cells raises intriguing questions about potential cross-talk between ATP storage and lysosomal maturation, a relationship previously underexplored in lymphocytes. Whether altered lysosomal pH or abundance indirectly modulates T cell activation through mechanisms independent of ATP release (e.g., antigen processing or mTOR signaling) remains an open avenue for investigation. Furthermore, the tissue specificity of this pathway merits scrutiny, given documented variations in VNUT expression across immune subsets and pathological contexts (4). Clinically, our work positions VNUT and its associated ATP-P2X7R axis as a tunable node for immunomodulation. The enhanced TH1 differentiation following disruption of this pathway suggests therapeutic potential in scenarios requiring bolstered cell–mediated immunity, such as chronic infections or malignancies. Conversely, targeted potentiation of VNUT activity could attenuate excessive TH1 responses in autoimmune disorders. Notably, the lysosome-specific nature of this mechanism may offer enhanced specificity compared to global ATP modulation, reducing off-target effects. Future studies exploring VNUT polymorphisms or expression patterns in patient cohorts could further validate its translational relevance. In conclusion, this study redefines VNUT as a gatekeeper of TH1 differentiation through lysosomal ATP transport, integrating metabolic and transcriptional networks to fine-tune immune responses. By elucidating a TCR-P2X7R-FOXO3a-Eomes axis governed by vesicular nucleotide dynamics, we advance a paradigm in which intracellular organelle function directly shapes adaptive immunity. These findings not only resolve mechanistic gaps in T cell signaling but also unveil previously unidentified therapeutic targets for diseases hinging on TH1 dysregulation. MATERIALS AND METHODS Study design The aim of this study was to investigate the function of VNUT in CD4+ T cells. Thus, we generated CD4+ T cell specific Vnut cKO mouse models. We primarily used flow cytometry, cell sorting, ChIP-qPCR, qPCR, Western blot, KLH immune model, Listeria infection model, and MC38 tumor transplantation in this study. All mice were housed in our animal facility at the University of California, San Diego, in accordance with the ethical guidelines of the Institutional Animal Care and Use Committee. Both male and female mice with age- and sex-matched control mice were used in the study. This study was not blinded. The numbers of samples and independent experiments are indicated in the figure legends. Mice Mice with floxed Vnut alleles (Vnutfl/fl) were brought from Cambridge-Suzhou Genomic Resource Center. C57BL/6 and Cd4Cre-transgenic mice (B6 background) were from the Jackson Laboratory and the National Cancer Institute, National Institutes of Health, respectively. Mice with T cell–specific deletion of Vnut were generated by crossing Vnutfl/fl mice with Cd4Cre-transgenic mice. The Vnutfl/fl Cd4Cre (Vnut-cKO) mice and Vnutfl/fl (WT) littermates on the mixed background were used in the experiments. All mice were maintained in specific pathogen–free animal facilities at Tsinghua University, and all animal experiments were carried out using 6- to 10-week-old mice. All experiments involving animals were conducted with the explicit permission granted by the Animal Ethics Committee of Tsinghua University, in accordance with their official guidelines and regulations (THU-02-2025-0019A). Murine naïve T cell stimulation and differentiation in vitro Naïve CD4+ CD25−CD62Lhi CD44low T cells from spleens and lymph nodes were isolated using a FACSAria sorter (BD Biosciences). Purified naïve T cells were stimulated with plate-bound anti-CD3 (5 μg/ml; 2C11, Bio X Cell) and anti-CD28 (5 μg/ml; 37.51, Bio X Cell) in the presence of IL-12 (20 ng/ml; Peprotech), anti–IL-4 (5 μg/ml), and IL-2 (40 U/ml) for the generation of TH1 cells; IL-4 (10 ng/ml; Peprotech), anti–IFN-γ (10 μg/ml), and IL-2 (40 U/ml) for the generation of TH2 cells; transforming growth factor–β1 (TGF-β1; 1 ng/ml; Peprotech), IL-6 (10 ng/ml; Peprotech), anti–IFN-γ (5 μg/ml), and anti–IL-4 (5 μg/ml) or IL-23 (10 ng/ml), IL-1β (10 ng/ml; Peprotech), IL-6 (10 ng/ml), anti–IFN-γ (5 μg/ml), and anti–IL-4 (5 μg/ml) for the generation of TH17 cells; and TGF-β1 (1 ng/ml), anti–IFN-γ (5 μg/ml), anti–IL-4 (5 μg/ml), and IL-2 (40 U/ml) for the generation of inducible regulatory T cell (iTreg) cells. Cells were cultured in complete medium [RPMI medium containing 10% fetal bovine serum (FBS), supplemented with penicillin-streptomycin and 2-mercaptoethanol] for 3 to 5 days, followed by intracellular staining and RNA preparation. Human naïve T cell isolation and differentiation in vitro Human PBMCs were used as the starting material for isolating human pan-T cells, which was performed via the Pan T Cell Isolation Kit (Miltenyi Biotec) following the manufacturer’s recommended protocol. For the purification of naïve CD4+ CD45RA+ CCR7+ T cells, fluorescence-activated cell sorting (FACS) was conducted using a FACSAria flow cytometer (BD Biosciences) to ensure high purity of the target cell subset. To induce TH1 cell polarization and differentiation, the purified naïve CD4+ T cells were seeded into culture wells precoated with antihuman CD3 antibody (4 μg/ml; UCHT1, Bio X Cell) and antihuman CD28 antibody (2 μg/ml; 9.3, Bio X Cell). The culture system was further supplemented with human IL-12 (20 ng/ml; Peprotech), antihuman IL-4 antibody (1 μg/ml), and human IL-2 (40 U/ml; Peprotech). All cell cultures were maintained in X-VIVO15 medium (Lonza) and incubated at 37°C in a humidified atmosphere containing 5% CO2 for a total of 7 days to complete TH1 cell differentiation. All experiments involving human samples were conducted with the explicit permission granted by the Science and Technology Ethics Committee of Tsinghua University, in accordance with their official guidelines and regulations (THU-01-2025-1035). Intracellular staining and flow cytometry Cells were restimulated for 5 hours with phorbol 12-myristate 13-acetate (50 ng/ml; MilliporeSigma), ionomycin (500 ng/ml; MilliporeSigma), and monensin (GolgiStop, BD Biosciences). After staining for cell-surface markers, intracellular staining was performed using the following buffers: Cytofix/Cytoperm (BD Biosciences) and Foxp3 staining buffer set (eBioscience). The flow cytometer FACSCalibur or LSRFortessa (both from BD Biosciences) and FlowJo software (Tree Star) were used for flow cytometry and data analysis. All antibodies used in this study are listed in table S1. Retroviral transduction FoxO3 and Eomes cDNA were PCR amplified and subcloned into pRVKM-MCS-IRES-GFR vector. Retrovirus production was carried out in 293T (American Type Culture Collection). Naïve CD4+ CD25−CD62Lhi CD44low T cells were isolated and stimulated with plate-bound anti-CD3 and anti-CD28 antibodies. Twenty hours after stimulation, the supernatant with virus particles was added, and spin transduction was performed in the presence of polybrene (8 μg/ml) at 900g for 90 min at 30°C. Next, intracellular staining, enzyme-linked immunosorbent assay (ELISA), and real-time qPCR were carried out after 3 days of culturing in the appropriate TH cell–polarizing conditions. For some applications, green fluorescent protein (GFP)+ and GFP− cells were sorted with a BD FACSAria. Real-time qPCR Total RNA was extracted using TRIzol reagent (TIANGEN). For analysis of mRNA transcripts, cDNA was generated by the PrimeScript RT reagent Kit with genomic DNA Eraser (TaKaRa) and amplified in 2× TransStart Top Green qPCR SuperMix (TransGen) in the presence of specific primer pairs. Data were normalized to the Actb gene for each sample. All primer sequences used in this study are listed in table S2. KLH immunization Mice were immunized subcutaneously twice with KLH (1 mg/ml) emulsified in FCA (0.5 mg/ml; 100 μl per mouse). After 2 weeks of immunization, mice were euthanized, and a series of analyses were performed. For intracellular cytokine staining, lymphocytes from lymph nodes and splenocytes were stimulated with KLH (0 and 100 μg/ml) for 24 hours in the presence of monensin in the last 5 hours, and, then, IFN-γ–producing cells were detected in the CD4+ cell population as described above. Listeria monocytogenes infection An erythromycin-resistant strain of L. monocytogenes (Lm)–ovalbumin (OVA; recombinant L. monocytogenes expressing a truncated OVA protein, amino acids 134 to 387) was grown in brain heart infusion medium supplemented with erythromycin (5 μg/ml). Age- and sex-matched WT and Vnut-cKO mice were intravenously injected with 105 CFU Lm-OVA in 100 μl of phosphate-buffered saline (PBS) and euthanized on day 7 after injection. The number of live bacteria lysates from infected organs was determined by measuring CFU. In brief, the livers and spleens were collected and homogenized, the homogenates were spread on brain heart infusion agar, and L. monocytogenes CFU were assessed after overnight growth at 37°C. For analysis of specific T cell responses, splenocytes and liver cells were stimulated with OVA257-264 (SIINFEKL) or LLO190-201 (NEKYAQA-YPNVS) peptide overnight, in the presence of monensin in the last 5 hours for intracellular cytokine staining or for 3 days for ELISA. For CD4+ T cell depletion, infected mice were treated with anti-CD4 antibody (GK1.5, Bio X Cell) intraperitoneally on days −1 and +1 relative to the challenge with Lm-OVA. Livers and spleens were harvested on day 7 after infection for enumeration of bacterial burden. MC38 tumor model The MC38-OVA tumor model was established using MC38 cells expressing OVA antigen cultured in Dulbecco’s modified Eagle’s medium containing 10% FBS. When cells reached optimal growth, they were harvested, resuspended in PBS at 1 × 107 cells/ml, and subcutaneously injected (100 μl) into the inguinal region of mice. Tumor volume was measured every 3 days using calipers until reaching 1000 mm3, at which point animals were euthanized via CO2 aspergation followed by immersion in 75% alcohol for 10 s. Tumors were excised, weighed, and processed for downstream analysis. For single-cell analysis, excised tumors were minced with scissors, digested in 10 ml of collagenase/dispase solution (RPMI 1640 based) at 37°C for 50 min, neutralized with culture medium, and filtered through a 100-μm mesh. Cells were pelleted, lysed with red blood cell lysis buffer, and resuspended in FACS buffer. For immunophenotyping, aliquots were stained with surface markers after CD16/32 blocking. For functional analysis, cells were fixed and permeabilized before staining intracellular cytokines/transcription factors. Flow cytometry was performed on an appropriate instrument following standard protocols. ChIP and ChIP-qPCR The ChIP experiment was performed using the SimpleChIP Plus Enzymatic Chromatin IP Kit (Magenetic Bead) [Cell Signaling Technology (CST)]. Brief, with anti-FoxO3 antibody (128290, CST) or rabbit immunoglobulin G (ab37415, Abcam). Primers for FoxO3a ChIP-qPCR were synthesized and are listed in table S2. Statistics All statistical analyses were performed with an unpaired, two-tailed Student’s t test or two-way analysis of variance (ANOVA) where appropriate using GraphPad Prism 9 (GraphPad software). A P value of less than 0.05 was considered statistically significant. Data are presented as the means ± SEM.